Abbott Laboratories vs Pinterest Inc — how do they compare? Abbott Laboratories trades at $110.74 (market cap $187.95B), while Pinterest Inc trades at $22.89 (market cap $13.45B). The key difference: Abbott Laboratories is far larger — about 14× Pinterest Inc's market cap, and Abbott Laboratories pays a 2.32% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals.
| ABT | PINS | |
|---|---|---|
Market Cap | $187.95B | $13.45B |
Sector | Health | Media |
52-Week High | $136.62 | $37.95 |
52-Week Low | $82.57 | $15.42 |
Enterprise Value | $214.96B | $13.37B |
Dividend Yield | 2.32% | — |
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $108.63, up 0.77% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages, though RSI indicates overbought conditions. Fundamentally, revenue grew to $44.33B in 2025 with a net income margin of 11.65%, while recent Q1 and Q2 2026 earnings beat expectations. The company maintains solid cash flow from operations of $9.57B and recently secured CE Mark for innovative dual glucose-ketone sensors, reinforcing its healthcare leadership.
Outlook remains positive with a consensus price target of $120.70, implying 11% upside, supported by 75.6% analyst buy ratings. Key risks include competitive pressures in diagnostics and macroeconomic sensitivity. The dividend yield and innovation pipeline offer stability, but investors should monitor execution on growth initiatives amid evolving market conditions.
Pinterest (PINS) trades at $24.37, up 2.91% with strong technical momentum as moving averages signal bullish sentiment. The company demonstrates solid fundamental performance with Q2 2026 EPS beating estimates at $0.43 versus $0.36 expected, marking the third consecutive quarterly beat. Revenue growth remains robust at 18% year-over-year, reaching $1.18 billion in Q2 2026, while maintaining a healthy gross profit margin of 79.47%.
The investment outlook appears favorable with 54% analyst buy ratings and a $28.69 consensus price target representing 18% upside potential. However, risks include intense advertising competition from Meta and slowing revenue guidance for Q3 2026. The stock offers value at current levels given strong AI-driven ad growth and record user metrics, though investors should monitor competitive pressures and execution on international expansion.
Trailing returns across standard periods
Latest headlines on both assets
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →